447 Differences in Demographics and Treatment Outcome of Chronic Hepatitis C (CHC) Patients of Different European Origin Treated with Peginterferon ALFA-2A (40KDA) and Ribavirin (Peg/RBV) (original ) (raw )Depressive Episode Incidence in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin
Izabella Corsino
Arquivos de Gastroenterologia, 2016
View PDFchevron_right
No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C
Ziad Kronfol
Journal of Affective Disorders, 2011
View PDFchevron_right
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C
Gunnar Norkrans
Hepatology, 2010
View PDFchevron_right
De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C
Felipe Andres Barria Garcia
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
Early prediction of major depression in chronic hepatitis C patients during peg-interferon α-2b treatment by assessment of vegetative-depressive symptoms after four weeks
F. Nevens
World Journal of Gastroenterology, 2007
View PDFchevron_right
Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C
Tafazzul-E-Haque Mahmud
Journal of Ayub Medical College, Abbottabad: JAMC
View PDFchevron_right
Quality of life, depression, and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy
Katia Falasca
Clinical and investigative medicine. Médecine clinique et experimentale, 2009
View PDFchevron_right
The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska
Visnja Banjac
Medical Archives
View PDFchevron_right
Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
Elfi Egmond
Revista Brasileira de Psiquiatria, 2019
View PDFchevron_right
Frequency of depression in chronic Hepatitis C naïve patients INTRODUCTION
Memon S Ali
View PDFchevron_right
Frequency of Depression in Chronic Hepatitis C naive patients
Abdul Memon
Pakistan Journal of Medical Sciences Online, 2011
View PDFchevron_right
ORIGINAL ARTICLES Depression within Hepatitis C virus patients: A case control study
amal abd
2019
View PDFchevron_right
Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C
Ziad Kronfol
2008
View PDFchevron_right
Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
Antonio Russo
Gastroenterology, 2010
View PDFchevron_right
Depression in patients with chronic hepatitis C treated with interferon (IFN) — alpha therapy
Dominik Maria Rosenauer
European Neuropsychopharmacology, 2001
View PDFchevron_right
Outcomes of Peginterferon alfa-2a and Ribavirin Combination Therapy in a Resident-Initiated, Multidisciplinary, Hepatitis C Clinic
K. Nadeem Ahmed
2007
View PDFchevron_right
Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation
Sarah Prieto
The International Journal of Psychiatry in Medicine, 2018
View PDFchevron_right
Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C
Andrew Miller
Brain, Behavior, and Immunity, 2005
View PDFchevron_right
Interferon-Induced Depression in Chronic Hepatitis C
Manuel Valdés
The Journal of Clinical Psychiatry, 2012
View PDFchevron_right
Depressive symptoms and viral clearance in patients receiving interferon-? and ribavirin for hepatitis C
Sherry Broadwell
Brain Behav Immun, 2005
View PDFchevron_right
Depression and pegylated interferon-based hepatitis C treatment
Murali Rao
International Journal of Interferon, Cytokine and Mediator Research, 2012
View PDFchevron_right
Predictors of Psychopathological Outcome During Peg-Interferon and Ribavirin Therapy in Patients with Chronic HCV-Correlated Hepatitis
Gian Luigi Prati
Journal of Interferon & Cytokine Research, 2013
View PDFchevron_right
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
Wan-long Chuang
Gut, 2007
View PDFchevron_right
The effect of direct antiviral treatment on the depression, anxiety, fatigue and quality-of-life in chronic hepatitis C patients
SEBATİ ÖZDEMİR
European Journal of Gastroenterology & Hepatology, 2019
View PDFchevron_right
Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study
Henrik Krarup
BMC Infectious Diseases, 2011
View PDFchevron_right
Treatment Response of Chronic Hepatitis C Patients and Health-Related Quality of Life
Nessrin El-Nimr
Journal of High Institute of Public Health, 2016
View PDFchevron_right
Haematological abnormalities and quality of life in patients with chronic hepatitis C who meet major depression disorder during antiviral therapy
Salvatore Calò
2010
View PDFchevron_right